CD19 and diffuse large B-cell lymphoma: Third, initial efforts to treat chronic lymphocytic leukemia (CLL) (by also targeting CD19) were somewhat disappointing,4,5 leading to a shift towards investigations in pediatric B-ALL (as well as towards adult diffuse large B-cell lymphoma; DLBCL).